J03 Evaluating tominersen effect on self-reported quality of life (QoL) with high-frequency longitudinal, digital euroqol 5-dimensions 5-level (EQ-5D-5L) survey in generation HD1, a phase III trial of tominersen in adult individuals with manifest Huntington’s disease (HD)

Abstract

BackgroundHigh-frequency, remote assessments of cognitive and motor symptoms in neurodegenerative diseases using smartphones have the potential to monitor disease progression and therapeutic interventions. Here, we report the digital EQ-5D-5L survey...